923
Participants
Start Date
October 31, 2007
Primary Completion Date
April 30, 2010
Study Completion Date
April 30, 2010
risedronate
5 mg Immediate-release Risedronate Administered At Least 30 Minutes Before Breakfast Daily
risedronate
35 mg Delayed-release Risedronate Administered Immediately Following Breakfast Weekly
risedronate
35 mg Delayed-release Risedronate Administered At Least 30 Minutes Before Breakfast Weekly
Research Site, Birmingham
Research Site, Oakland
Research Site, San Diego
Research Facility, Walnut Creek
Research Site, Walnut Creek
Research Site, Lakewood
Research Site, Leesburg
Research Site, Melbourne
Research Site, South Miami
Research Site, Gainesville
Research Site, Champaign
Research Site, Chicago
Research Site, Bethesda
Research Site, Brockton
Research Site, Omaha
Research Site, Las Vegas
Research Site, Greenville
Research Site, Portland
Research Site, Seattle
Research Site, Madison
Research Site, Buenos Aires
Research Facility, Diepenbeek
Research Site, Ghent
Research Site, Leuven
Research Site, Hamilton
Research Site, Kitchener
Research Site, Newmarket
Research Site, Montreal
Research Site, Québec
Research Site, Saint-Eustache
Research Site, Saskatoon
Research Site, Pärnu
Research Site, Tallinn
Research Site, Tartu
Research Site, Amiens
Research Site, Lyon
Research Site, Orléans
Research Site, Vandœuvre-lès-Nancy
Research Site, Balatonfüred
Research Site, Debrecen
Research Site, Eger
Research Site, Győr
Research Site, Koranyi Sandor
Research Site, Bialystok
Research Site, Warsaw
Lead Sponsor
Warner Chilcott
INDUSTRY